spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

The Mobile Health/Central Lab Interface, an opportunity for DCT efficiency

mdgroup

 How streamlining relations between central labs and mobile health providers can get the most from hybrid and decentralised clinical trials



Bracknell, UK, 1 December 2022 - As the conversation around hybrid and decentralised clinical trials (DCT) moves from why to how, sponsors are increasingly seeking the best ways to embed the new model into their routine workflows.

As part of the Decentralized Trials and Research Alliance’s (DTRA) TGIF-DCT podcast series, global MedTech and patient servicing provider mdgroup will join forces with global clinical trial laboratory Q2 Solutions to explain how tearing down barriers between the various vendors and service providers involved in such studies is a simple yet effective starting point. Hosted by DTRA founder Craig Lipset, mdgroup’s Director of Decentralised Clinical Solutions, Tom Brazier, will present with Q2 Solutions’ Decentralised Trial Solutions Director, John Corcoran, and Manager, Stephanie Larimer.

“From sponsors to CROs and vendors, we all need to think about how to streamline the logistics of DCTs, which tend to be conducted using a patchwork of different service providers and vendors – including mobile health providers, who collect the clinical samples, and central laboratories, who analyse them,” Tom Brazier explains.

“Despite each of these service providers being dependent on the other to do their job, there is often no direct line of contact between the two. Instead, the shared client becomes the key liaison for both, impairing effective communication, draining clinical trial efficiency, and placing additional burden on the sponsor.”

The group will consider how the absence of communication between central laboratories and mobile health providers can contribute to inefficiencies, lead to duplicated efforts, and put data quality at risk. By opening lines of communication between these two parties, the discussion will illustrate how critical areas such as study set up and sample kit logistics can be streamlined, while protecting data quality.

This event will take place on 9 December, 12-1pm, EST. This podcast discussion forms part of a series of Clubhouse events, organised by the DTRA, of which mdgroup is a founding member, aimed at providing all stakeholders with an informal space to share DCT experiences and best practice.

TGIF-DCT meets every Friday 12-1pm EST for an informal space to share experiences in #decentralizedtrials on Clubhouse. To listen and for more information on TGIF-DCT: The Decentralized Trials Club, visit https://www.linkedin.com/events/tgif-dct-labs-specimensanddecen6983621269157986304/about/ or find Clubhouse to download the app on your device.
phone +44 1344 300 808
email info@mdgroup.com
web https://www.mdgroup.com/
email Building 329, Doncastle Road, Bracknell, Berkshire, RG12 8PE
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Kayentis and ClinOne join forces to improve efficiency and patient experience in clinical trials

Grenoble, France, and Needham (MA), US, January 10, 2023 – Kayentis, a global provider of electronic Clinical Outcome Assessment (eCOA) and Decentralized Clinical Trial (DCT) solutions, and ClinOne, a leading provider for adaptive clinical trial experiences for patients, families and clinical sites, today announce a strategic alliance. This collaboration combines Kayentis’ expertise in clinical trial data collection with ClinOne’s best-in-class consent management and patient engagement technology. Together, they enable patients and sites to access a complete range of DCT solutions with a single point of entry for all types of trials – from traditional to fully decentralized.
More info >>


White Papers

Tabletability, Compactability, and Compressibilty: What’s the Difference?

Natoli Engineering Company, Inc.

To patients and consumers, tablets are a simple and convenient dosage form. But the science behind compressing a block of particles or granules into a single tablet can be complicated. That’s where common compression studies can help. This article explains how to develop tabletability, compactibility, and compressibility profiles.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement